Medinfar awarded first ever CPHI Verified Certificate
CPHI Verified certification improves supply chain transparency, providing a legal, regulatory and quality benchmark
CPHI has awarded the first ever CPHI Verified certificate to Medinfar – an international pharmaceutical manufacturer of Rx, cosmetics, food supplements and veterinary products.
The new certification was given after a detailed evaluation by SGS – the world’s leading verification, inspection and certification company – spanning some 14 separate criteria, including the company’s approach to quality and environmental management, supply chain, health and safety and business continuity planning.
CPHI Verified, developed in partnership with SGS, empowers pharmaceutical buyers with an established benchmark of legal, regulatory, quality and brand pre-qualification compliance. The service forms part of the platinum membership on CPHI Online and is designed to further supply chain trust and transparency.
CPHI Online launched the service in response to customer requests for an easily recognisable global benchmark for quality and integrity, especially as companies seek to develop wider networks of global partners.
“We congratulate Medinfar on becoming the first CPHI Verified manufacturer, its well-deserved recognition of the quality of their credentials and we look forward to building a database of trusted suppliers," said Patrick Steenvoorden, Digital Director at CPHI.
“We have partnered on this programme with CPHI, the largest pharmaceutical trade show organiser and online community, to help suppliers communicate their level of compliance and adherence to various criteria. We are so pleased to welcome the very first partner to the CPHI Verified family and commend the Medinfar team on this achievement,” commented Kristofer Whitfield, Head of Delivery at SGS.
For more information about CPHI Verified, please visit CPHI Online – the largest and most trusted marketplace and content hub available to pharma professionals.
Related News
-
News A Day in the Life of a Vice President of Business Development
In this month's Day in the Life Of interview, I spoke to Nigel Stapleton, VP of Business Development in Biopharmaceutical Contract Manufacturing for Mabion SA, about his illustrious career and some personal highlights. -
News Pharmaceutical Packaging Market Prospects: Shifting regional policies
The pharmaceutical packaging industry is experiencing significant transformation in 2025, driven by regulatory changes, supply chain challenges, and sustainability initiatives. The US BIOSECURE Act, passed through the House of Representatives in Septem... -
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News China import tax fine could cost AstraZeneca up to US$8 million
British-Swedish drugmaker AstraZeneca could find itself facing fines of up to US$8million in China due to suspected unpaid import taxes on breast cancer drug Enhertu.
-
News Women in Pharma: Building from the ground up together
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive... -
News Pharmaceutical Packaging Market Prospects – Innovations in Packaging and Drug Delivery
Download the Pharmaceutical Packaging Market Prospects Trend Report to explore the full report and delve into the evolving opportunities in pharmaceutical packaging and drug delivery. -
News Novartis to invest US$23 billion in US facilities amid tariff threats
Swiss pharmaceutical giant Novartis has announced its intention to invest up to US$23 billion in building and expanding ten pharmaceutical facilities in the US as drugmakers scramble to respond to potential drug import and manufacturing tariffs declare... -
News CPHI Podcast Series: Fulfilling an unmet need for rare disease patients
Our April episode from the CPHI Podcast Series is looking into rare diseases, and more specifically how pharmaceutical companies can better support this smaller population of rare disease patients.